345 related articles for article (PubMed ID: 35011678)
1. Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies.
Attia N; Mashal M; Pemminati S; Omole A; Edmondson C; Jones W; Priyadarshini P; Mughal T; Aziz P; Zenick B; Perez A; Lacken M
Cells; 2021 Dec; 11(1):. PubMed ID: 35011678
[TBL] [Abstract][Full Text] [Related]
2. CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy.
Burger MC; Zhang C; Harter PN; Romanski A; Strassheimer F; Senft C; Tonn T; Steinbach JP; Wels WS
Front Immunol; 2019; 10():2683. PubMed ID: 31798595
[TBL] [Abstract][Full Text] [Related]
3. CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells.
Han J; Chu J; Keung Chan W; Zhang J; Wang Y; Cohen JB; Victor A; Meisen WH; Kim SH; Grandi P; Wang QE; He X; Nakano I; Chiocca EA; Glorioso Iii JC; Kaur B; Caligiuri MA; Yu J
Sci Rep; 2015 Jul; 5():11483. PubMed ID: 26155832
[TBL] [Abstract][Full Text] [Related]
4. Current clinical management of patients with glioblastoma.
Lowe S; Bhat KP; Olar A
Cancer Rep (Hoboken); 2019 Dec; 2(6):e1216. PubMed ID: 32721125
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma Therapy: Past, Present and Future.
Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
[TBL] [Abstract][Full Text] [Related]
6. Stem cell-based therapy treating glioblastoma multiforme.
Abadi B; Ahmadi-Zeidabadi M; Dini L; Vergallo C
Hematol Oncol Stem Cell Ther; 2021 Mar; 14(1):1-15. PubMed ID: 32971031
[TBL] [Abstract][Full Text] [Related]
7. Adult cerebellar glioblastoma: understanding survival and prognostic factors using a population-based database from 1973 to 2009.
Adams H; Chaichana KL; Avendaño J; Liu B; Raza SM; Quiñones-Hinojosa A
World Neurosurg; 2013 Dec; 80(6):e237-43. PubMed ID: 23395851
[TBL] [Abstract][Full Text] [Related]
8. GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma.
Gargett T; Ebert LM; Truong NTH; Kollis PM; Sedivakova K; Yu W; Yeo ECF; Wittwer NL; Gliddon BL; Tea MN; Ormsby R; Poonnoose S; Nowicki J; Vittorio O; Ziegler DS; Pitson SM; Brown MP
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36167468
[TBL] [Abstract][Full Text] [Related]
9. Engineered cells as glioblastoma therapeutics.
Ramanathan A; Lorimer IAJ
Cancer Gene Ther; 2022 Feb; 29(2):156-166. PubMed ID: 33753869
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds.
Asija S; Chatterjee A; Yadav S; Chekuri G; Karulkar A; Jaiswal AK; Goda JS; Purwar R
Int Rev Immunol; 2022; 41(6):582-605. PubMed ID: 35938932
[TBL] [Abstract][Full Text] [Related]
11. Chimeric Antigen Receptor T-Cell Therapy: Updates in Glioblastoma Treatment.
Feldman L; Brown C; Badie B
Neurosurgery; 2021 May; 88(6):1056-1064. PubMed ID: 33575786
[TBL] [Abstract][Full Text] [Related]
12. The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics.
Perez JG; Tran NL; Rosenblum MG; Schneider CS; Connolly NP; Kim AJ; Woodworth GF; Winkles JA
Oncogene; 2016 Apr; 35(17):2145-55. PubMed ID: 26300004
[TBL] [Abstract][Full Text] [Related]
13. Sonodynamic therapy and magnetic resonance-guided focused ultrasound: new therapeutic strategy in glioblastoma.
Bonosi L; Marino S; Benigno UE; Musso S; Buscemi F; Giardina K; Gerardi R; Brunasso L; Costanzo R; Iacopino DG; Maugeri R
J Neurooncol; 2023 May; 163(1):219-238. PubMed ID: 37179515
[TBL] [Abstract][Full Text] [Related]
14. Cell-based immunotherapy against gliomas: from bench to bedside.
Bovenberg MS; Degeling MH; Tannous BA
Mol Ther; 2013 Jul; 21(7):1297-305. PubMed ID: 23648695
[TBL] [Abstract][Full Text] [Related]
15. IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma.
Ladomersky E; Zhai L; Lenzen A; Lauing KL; Qian J; Scholtens DM; Gritsina G; Sun X; Liu Y; Yu F; Gong W; Liu Y; Jiang B; Tang T; Patel R; Platanias LC; James CD; Stupp R; Lukas RV; Binder DC; Wainwright DA
Clin Cancer Res; 2018 Jun; 24(11):2559-2573. PubMed ID: 29500275
[No Abstract] [Full Text] [Related]
16. Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?
Ruiz-Molina D; Mao X; Alfonso-Triguero P; Lorenzo J; Bruna J; Yuste VJ; Candiota AP; Novio F
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230883
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a new glioblastoma cell line, GB-val4, with unusual TP53 mutation.
Muñoz-Hidalgo L; San-Miguel T; Megías J; Gil-Benso R; Cerdá-Nicolás M; López-Ginés C
Hum Cell; 2019 Oct; 32(4):557-567. PubMed ID: 31388924
[TBL] [Abstract][Full Text] [Related]
18. SRC family kinase inhibition through a new pyrazolo[3,4-d]pyrimidine derivative as a feasible approach for glioblastoma treatment.
Ceccherini E; Indovina P; Zamperini C; Dreassi E; Casini N; Cutaia O; Forte IM; Pentimalli F; Esposito L; Polito MS; Schenone S; Botta M; Giordano A
J Cell Biochem; 2015 May; 116(5):856-63. PubMed ID: 25521525
[TBL] [Abstract][Full Text] [Related]
19. Stem cell-based therapies for tumors in the brain: are we there yet?
Shah K
Neuro Oncol; 2016 Aug; 18(8):1066-78. PubMed ID: 27282399
[TBL] [Abstract][Full Text] [Related]
20. A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases.
Chen X; Han J; Chu J; Zhang L; Zhang J; Chen C; Chen L; Wang Y; Wang H; Yi L; Elder JB; Wang QE; He X; Kaur B; Chiocca EA; Yu J
Oncotarget; 2016 May; 7(19):27764-77. PubMed ID: 27050072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
